Pharmaceutical Company Says FDA’s Approval Of Generic Drug Violated FDCA
WASHINGTON, D.C. — A pharmaceutical company moved for summary judgment in its suit against the U.S. Food and Drug Administration, asking a federal judge in the District of Columbia to order...To view the full article, register now.
Already a subscriber? Click here to view full article